Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
O14561
UPID:
ACPM_HUMAN
Alternative names:
CI-SDAP; NADH-ubiquinone oxidoreductase 9.6 kDa subunit
Alternative UPACC:
O14561; B2R4M1; Q9UNV1
Background:
Acyl carrier protein, mitochondrial, also known as CI-SDAP and NADH-ubiquinone oxidoreductase 9.6 kDa subunit, plays a pivotal role in fatty acid biosynthesis and mitochondrial respiratory chain function. It acts as a carrier for the growing fatty acid chain, facilitating electron transfer in the respiratory chain and participating in the assembly of iron-sulfur clusters, essential for mitochondrial iron-sulfur protein biogenesis.
Therapeutic significance:
Understanding the role of Acyl carrier protein, mitochondrial could open doors to potential therapeutic strategies.